Onyx-ONE Clear

Objective

The purpose of this study is to evaluate the clinical safety and effectiveness of the Resolute Onyx stent in subjects deemed at high risk for bleeding and/or medically unsuitable for more than one-month DAPT treatment receiving reduced duration (one month) of DAPT following stent implantation.

View this clinical trail on ClinicalTrials.gov.

Location:

Essentia Health East

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 12/06/2018

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.